Djentinga

Low Risk Long Entry SELB

做多
Djentinga 已更新   
NASDAQ:SELB   None
1. Price near support + trendline.
2. Bullish divergence on the MACD.
3. ADX below 20 indicating that the sell off is weak.
4. Low volume sell off in line with rest of market/XBI.
5. Insider Dr. Timothy Springer (who made ~17000% on MRNA) keeps buying millions of shares above this level.

交易结束:到达止损:
Not yet it seems :)
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。